Why Relay Therapeutics Stock Popped on Wednesday
One trading session after Relay Therapeutics (NASDAQ: RLAY) announced positive results for an investigational treatment, its shares rocketed higher on Wednesday. That rally, which saw the biotech stock rocket almost 8% higher, was aided in no small part by a pair of bullish analyst updates.
Those new analyses came on the heels of Relay's Tuesday release of Phase 2 results for zovegalisib, a drug that treats vascular anomalies. The company said that, across all doses of the medication, 60% of tested patients responded to treatment at the earliest time point of 12 weeks.
Image source: Getty Images.
Source Fool.com
